This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Ventas Stock Rallies 24.5% in Six Months: Will the Trend Last?
by Zacks Equity Research
VTR shares rise 24.5% in six months, far outperforming the industry, as strong SHOP growth and balance sheet gains lift sentiment.
The Longevity Shift: Healthcare REITs to Benefit From Global Aging
by Urmimala Biswas
WELL, VTR, CTRE and OHI are tapping the longevity economy as aging populations drive rising demand for senior housing, skilled nursing and long-term care real estate.
Key Reasons to Add Ventas Stock to Your Portfolio Right Now
by Zacks Equity Research
VTR gains momentum as its healthcare real estate portfolio, research investments and solid balance sheet point to further growth potential.
Why Is SBA Communications (SBAC) Down 4.7% Since Last Earnings Report?
by Zacks Equity Research
SBA Communications (SBAC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Ventas (VTR) Up 7.7% Since Last Earnings Report?
by Zacks Equity Research
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are You Looking for a Top Momentum Pick? Why Ventas (VTR) is a Great Choice
by Zacks Equity Research
Does Ventas (VTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ventas Stock Rallies 16.2% in Three Months: Will It Continue to Gain?
by Zacks Equity Research
VTR's expanding SHOP footprint, rising cash NOI and active capital recycling underscore its growth momentum.
Ventas Q3 FFO and Revenues Beat Estimates, Same-Store Cash NOI Rises
by Zacks Equity Research
VTR posts strong Q3 results with higher FFO and revenues, fueled by gains in senior housing and outpatient medical portfolios.
Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ventas (VTR) Q3 FFO and Revenues Top Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of +1.15% and +3.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?